Increasing placebo responses over time in U.S. clinical trials of neuropathic pain

@article{Tuttle2015IncreasingPR,
  title={Increasing placebo responses over time in U.S. clinical trials of neuropathic pain},
  author={A. Tuttle and Sarasa Tohyama and T. Ramsay and J. Kimmelman and P. Schweinhardt and G. Bennett and J. Mogil},
  journal={PAIN},
  year={2015},
  volume={156},
  pages={2616–2626}
}
Abstract Recent failures of clinical trials of novel analgesics designed to treat neuropathic pain have led to much speculation about the underlying reasons. One often discussed possibility is that the placebo response in these trials has increased in recent years, leading to lower separation between the drug and placebo arms. Whether this has indeed occurred has not yet been adequately addressed. Here, we extracted data from published randomized controlled trials (RCTs) of drugs for the… Expand
Additional considerations for increasing placebo response.
Can knowledge of Placebo and Nocebo Mechanisms Help Improve Randomized Clinical Trials?
Size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials.
Placebo response in neuropathic pain after spinal cord injury: a meta-analysis of individual participant data
How May Placebo Mechanisms Influence Orofacial Neuropathic Pain?
Pain, placebo, and test of treatment efficacy: a narrative review.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 43 REFERENCES
Placebo response in neuropathic pain trials
Clinical trial outcome in neuropathic pain
On the importance of placebo timing in rTMS studies for pain relief
Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.
...
1
2
3
4
5
...